Q3 2019 13F Holders as of 9/30/2019
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
51.1M
-
Number of holders
-
158
-
Total 13F shares, excl. options
-
28.6M
-
Shares change
-
-187K
-
Total reported value, excl. options
-
$1.02B
-
Value change
-
-$22M
-
Put/Call ratio
-
1.08
-
Number of buys
-
83
-
Number of sells
-
-80
-
Price
-
$35.60
Significant Holders of REGENXBIO Inc. - Common Stock, par value $0.0001 per share (RGNX) as of Q3 2019
203 filings reported holding RGNX - REGENXBIO Inc. - Common Stock, par value $0.0001 per share as of Q3 2019.
REGENXBIO Inc. - Common Stock, par value $0.0001 per share (RGNX) has 158 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 28.6M shares
of 51.1M outstanding shares and own 55.87% of the company stock.
Largest 10 shareholders include BlackRock Inc. (5.15M shares), VANGUARD GROUP INC (3.19M shares), Redmile Group, LLC (2.36M shares), STATE STREET CORP (2.1M shares), Carmignac Gestion (1.24M shares), JPMORGAN CHASE & CO (1.23M shares), WS MANAGEMENT LLLP (958K shares), DIMENSIONAL FUND ADVISORS LP (642K shares), PERCEPTIVE ADVISORS LLC (608K shares), and PRICE T ROWE ASSOCIATES INC /MD/ (573K shares).
This table shows the top 158 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.